Search for: "APP Pharmaceuticals, LLC" Results 41 - 60 of 132
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Aug 2011, 5:25 pm by FDABlog HPM
Those patents, issued on September 1, 2009 (the ‘727 Patent) and October 6, 2009 (the ‘343 Patent), were timely submitted to FDA for Orange Book listing, and served as flypaper for Paragraph IV patent certifications from several ANDA sponsors, including APP Pharmaceuticals, LLC (“APP”), the company embroiled in a battle with MDCO in the Federal Circuit over a PTE for the ‘404 Patent.  [read post]
6 Feb 2011, 10:41 am by FDABlog HPM
Court of Appeals for the Federal Circuit has denied MDCO’s Motion to Dismiss or, in the Alternative, to Bifurcate and Stay in Part APP Pharmaceuticals, LLC’s (“APP’s”) appeal related to Judge Claude M. [read post]
13 Jan 2012, 8:16 am
The Consumer Electronics Association, which is behind the show, has been a vocal opponent of the two bills circulating in Congress that would help Hollywood titans, record labels and pharmaceutical firms enforce copyright infringement laws online. [read post]
16 Nov 2012, 6:14 am by Gene Quinn
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
7 Jul 2011, 2:31 pm by Bexis
APP Pharmaceuticals, LLC, 2010 WL 4941451, at *4 (D.N.J. [read post]
9 Feb 2012, 4:06 pm by FDABlog HPM
ANDA sponsor APP Pharmaceuticals, LLC (“APP”) attempted to intervene in the PTE litigation before Judge Hilton; however, APP’s Motion to Intervene was denied.  [read post]
20 Apr 2011, 5:21 pm by FDABlog HPM
Court of Appeals for the Federal Circuit denied MDCO’s Motion to Dismiss or, in the Alternative, to Bifurcate and Stay in Part APP Pharmaceuticals, LLC’s (“APP’s”) appeal related to Judge Claude M. [read post]
10 Mar 2011, 11:00 am by Scott A. McKeown
Recently, the court in APP Pharmaceuticals, LLC v. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
14 Nov 2011, 4:46 pm by FDABlog HPM
Court of Appeals for the Federal Circuit notifying the Court of the enactment of Section 37 and asserting that it resolves the merits of the ongoing ‘404 patent PTE litigation with ANDA sponsor APP Pharmaceuticals, LLC (“APP”).  [read post]
15 Nov 2013, 11:34 am by Bexis
Anodyne Therapy, LLC, 589 F.3d 881, 884 (7th Cir. 2009).Once FDA-approved, prescription drugs can be prescribed by doctors for both FDA-approved and -unapproved uses; the FDA generally does not regulate how physicians use approved drugs . . . . [read post]